

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.41434768 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.41434768 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.16097880 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.16097880 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.56677532 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.41861098 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.39003621 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.19897187 |
| 9 | lysine catabolic process (GO:0006554) | 5.07733978 |
| 10 | lysine metabolic process (GO:0006553) | 5.07733978 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.03351639 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.03048832 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.92287238 |
| 14 | cysteine metabolic process (GO:0006534) | 4.87589254 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.82765561 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.82765561 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.82765561 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80689031 |
| 19 | protein carboxylation (GO:0018214) | 4.74937940 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.74937940 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.60932432 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.56071761 |
| 23 | urea cycle (GO:0000050) | 4.53898366 |
| 24 | urea metabolic process (GO:0019627) | 4.53898366 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.48653508 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.46137020 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.43773875 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 4.40537104 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.37747368 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.36154762 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.30237838 |
| 32 | regulation of female receptivity (GO:0045924) | 4.26915202 |
| 33 | bile acid metabolic process (GO:0008206) | 4.24485888 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.22477108 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.17457806 |
| 36 | regulation of complement activation (GO:0030449) | 4.12673660 |
| 37 | ethanol oxidation (GO:0006069) | 4.09504593 |
| 38 | somite development (GO:0061053) | 4.09064689 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.08005123 |
| 40 | fatty acid beta-oxidation (GO:0006635) | 4.06903814 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.05155651 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 4.03020728 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.00155756 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 3.99170903 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 3.97462596 |
| 46 | acylglycerol homeostasis (GO:0055090) | 3.97117040 |
| 47 | triglyceride homeostasis (GO:0070328) | 3.97117040 |
| 48 | piRNA metabolic process (GO:0034587) | 3.96681071 |
| 49 | acetyl-CoA metabolic process (GO:0006084) | 3.95398081 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 3.94008633 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.93616406 |
| 52 | fatty acid oxidation (GO:0019395) | 3.88322240 |
| 53 | aspartate family amino acid catabolic process (GO:0009068) | 3.85744593 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85010507 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 3.85010507 |
| 56 | macromolecular complex remodeling (GO:0034367) | 3.85010507 |
| 57 | tyrosine metabolic process (GO:0006570) | 3.84127714 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.84100746 |
| 59 | valine metabolic process (GO:0006573) | 3.83789530 |
| 60 | lipid oxidation (GO:0034440) | 3.81639602 |
| 61 | cellular glucuronidation (GO:0052695) | 3.81213574 |
| 62 | rRNA catabolic process (GO:0016075) | 3.78934684 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.78565697 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.77928772 |
| 65 | negative regulation of sterol transport (GO:0032372) | 3.77928772 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.77576601 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.77295671 |
| 68 | fatty acid catabolic process (GO:0009062) | 3.77066385 |
| 69 | epoxygenase P450 pathway (GO:0019373) | 3.72587712 |
| 70 | glutamate metabolic process (GO:0006536) | 3.71244702 |
| 71 | monocarboxylic acid catabolic process (GO:0072329) | 3.70432329 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.66445186 |
| 73 | phospholipid efflux (GO:0033700) | 3.65526248 |
| 74 | carnitine metabolic process (GO:0009437) | 3.64863118 |
| 75 | positive regulation of lipid catabolic process (GO:0050996) | 3.63899879 |
| 76 | ketone body metabolic process (GO:1902224) | 3.62184861 |
| 77 | regulation of mesoderm development (GO:2000380) | 3.61025473 |
| 78 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.58389562 |
| 79 | fatty acid transmembrane transport (GO:1902001) | 3.58020819 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.55945056 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.55681697 |
| 82 | bile acid and bile salt transport (GO:0015721) | 3.55032878 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.55002329 |
| 84 | DNA deamination (GO:0045006) | 3.54004741 |
| 85 | organic acid catabolic process (GO:0016054) | 3.53982514 |
| 86 | carboxylic acid catabolic process (GO:0046395) | 3.53982514 |
| 87 | behavioral response to nicotine (GO:0035095) | 3.52935482 |
| 88 | interkinetic nuclear migration (GO:0022027) | 3.52380663 |
| 89 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.51858057 |
| 90 | drug catabolic process (GO:0042737) | 3.51193839 |
| 91 | female mating behavior (GO:0060180) | 3.50885204 |
| 92 | regulation of cholesterol metabolic process (GO:0090181) | 3.47421266 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.45702328 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.38581017 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.38581017 |
| 96 | serine family amino acid metabolic process (GO:0009069) | 3.38535114 |
| 97 | cholesterol efflux (GO:0033344) | 3.38204788 |
| 98 | fibrinolysis (GO:0042730) | 3.36175728 |
| 99 | indolalkylamine metabolic process (GO:0006586) | 3.35720133 |
| 100 | glycine metabolic process (GO:0006544) | 3.34916015 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.34771917 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.31720186 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.31305672 |
| 104 | positive regulation of fatty acid oxidation (GO:0046321) | 3.30081203 |
| 105 | plasma lipoprotein particle assembly (GO:0034377) | 3.30068128 |
| 106 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.29936687 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.29451827 |
| 108 | drug transmembrane transport (GO:0006855) | 3.29124204 |
| 109 | carnitine shuttle (GO:0006853) | 3.28858417 |
| 110 | sterol homeostasis (GO:0055092) | 3.28038752 |
| 111 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.25695409 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.24594817 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.24594817 |
| 114 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.19429761 |
| 115 | positive regulation of meiosis (GO:0045836) | 3.16969604 |
| 116 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.11042860 |
| 117 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.09718588 |
| 118 | L-fucose catabolic process (GO:0042355) | 3.04695320 |
| 119 | fucose catabolic process (GO:0019317) | 3.04695320 |
| 120 | L-fucose metabolic process (GO:0042354) | 3.04695320 |
| 121 | adaptation of signaling pathway (GO:0023058) | 3.01258061 |
| 122 | detection of light stimulus involved in visual perception (GO:0050908) | 2.97257682 |
| 123 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.97257682 |
| 124 | DNA methylation involved in gamete generation (GO:0043046) | 2.96498781 |
| 125 | protein polyglutamylation (GO:0018095) | 2.95336713 |
| 126 | positive regulation of glomerulus development (GO:0090193) | 2.95134817 |
| 127 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.91528517 |
| 128 | positive regulation of meiotic cell cycle (GO:0051446) | 2.88570620 |
| 129 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.86192252 |
| 130 | regulation of glomerulus development (GO:0090192) | 2.82911565 |
| 131 | negative regulation of mast cell activation (GO:0033004) | 2.82721211 |
| 132 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.79807901 |
| 133 | negative regulation of stress fiber assembly (GO:0051497) | 2.78794592 |
| 134 | axoneme assembly (GO:0035082) | 2.78754665 |
| 135 | transmission of nerve impulse (GO:0019226) | 2.78070143 |
| 136 | primary amino compound metabolic process (GO:1901160) | 2.76096778 |
| 137 | prostate gland growth (GO:0060736) | 2.74055609 |
| 138 | membrane depolarization during action potential (GO:0086010) | 2.71741142 |
| 139 | aggressive behavior (GO:0002118) | 2.71028751 |
| 140 | serotonin metabolic process (GO:0042428) | 2.70253679 |
| 141 | indole-containing compound metabolic process (GO:0042430) | 2.69652481 |
| 142 | regulation of skeletal muscle contraction (GO:0014819) | 2.68651595 |
| 143 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.68523441 |
| 144 | rhodopsin mediated signaling pathway (GO:0016056) | 2.68225979 |
| 145 | kidney morphogenesis (GO:0060993) | 2.67872419 |
| 146 | neuronal action potential (GO:0019228) | 2.67473455 |
| 147 | regulation of action potential (GO:0098900) | 2.67084333 |
| 148 | action potential (GO:0001508) | 2.66943355 |
| 149 | epithelial cilium movement (GO:0003351) | 2.66445638 |
| 150 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.66184500 |
| 151 | endoderm formation (GO:0001706) | 2.64976391 |
| 152 | thyroid hormone metabolic process (GO:0042403) | 2.62488177 |
| 153 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.59165529 |
| 154 | gamma-aminobutyric acid transport (GO:0015812) | 2.57175606 |
| 155 | cornea development in camera-type eye (GO:0061303) | 2.56645451 |
| 156 | parturition (GO:0007567) | 2.56439473 |
| 157 | negative regulation of neurotransmitter transport (GO:0051589) | 2.56094848 |
| 158 | regulation of neurotransmitter uptake (GO:0051580) | 2.54761783 |
| 159 | pharyngeal system development (GO:0060037) | 2.53907737 |
| 160 | regulation of sequestering of triglyceride (GO:0010889) | 2.53576760 |
| 161 | positive regulation of organelle assembly (GO:1902117) | 2.51963045 |
| 162 | embryonic epithelial tube formation (GO:0001838) | 2.51495370 |
| 163 | sulfation (GO:0051923) | 2.49926454 |
| 164 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.48295021 |
| 165 | protein K6-linked ubiquitination (GO:0085020) | 2.47815138 |
| 166 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.46789524 |
| 167 | glycerophospholipid catabolic process (GO:0046475) | 2.46701175 |
| 168 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.46207415 |
| 169 | protein K11-linked deubiquitination (GO:0035871) | 2.45793656 |
| 170 | negative regulation of astrocyte differentiation (GO:0048712) | 2.43961327 |
| 171 | dentate gyrus development (GO:0021542) | 2.43832182 |
| 172 | dopamine transport (GO:0015872) | 2.39610150 |
| 173 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.39190512 |
| 174 | male meiosis (GO:0007140) | 2.38138076 |
| 175 | inositol phosphate catabolic process (GO:0071545) | 2.36134227 |
| 176 | adenosine metabolic process (GO:0046085) | 2.34728314 |
| 177 | regulation of DNA endoreduplication (GO:0032875) | 2.33427864 |
| 178 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.32933278 |
| 179 | regulation of acrosome reaction (GO:0060046) | 2.32511788 |
| 180 | male meiosis I (GO:0007141) | 2.32454337 |
| 181 | reflex (GO:0060004) | 2.31398394 |
| 182 | exogenous drug catabolic process (GO:0042738) | 2.29732525 |
| 183 | multicellular organismal signaling (GO:0035637) | 2.29331883 |
| 184 | regulation of germinal center formation (GO:0002634) | 2.28661879 |
| 185 | cellular response to ATP (GO:0071318) | 2.28387827 |
| 186 | oxidative demethylation (GO:0070989) | 2.28366400 |
| 187 | pancreas development (GO:0031016) | 2.27999688 |
| 188 | cAMP catabolic process (GO:0006198) | 2.27639042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.98409077 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.03778754 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.25869741 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.15713347 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57772019 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.82134637 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.32538229 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.63080545 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.47526674 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.46057459 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45219566 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.16002239 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.06183543 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.92366730 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.86545079 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.85842507 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.62862717 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.56484477 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.48001740 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.39327878 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38339906 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.11078934 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08699839 |
| 24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03879803 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03680416 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99028063 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90770973 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.89688553 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.84911171 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82457911 |
| 31 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77945701 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77941586 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76509142 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76169068 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72552722 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72071144 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68889674 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67422997 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67124299 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65290474 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64255349 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.64143369 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61583483 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57694226 |
| 45 | TCF4_23295773_ChIP-Seq_U87_Human | 1.57145279 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57056154 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.56643822 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56328151 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55390138 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.54445431 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53994695 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52967282 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.51819504 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49811935 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49470048 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48365305 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.47374726 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45581869 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44761467 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.44635460 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42510594 |
| 62 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41901632 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40281667 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39623956 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39398061 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.38824647 |
| 67 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38390694 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38336785 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37099427 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35310356 |
| 71 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35138622 |
| 72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35090534 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34507350 |
| 74 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.34037156 |
| 75 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33083706 |
| 76 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33060453 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32064491 |
| 78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31799720 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31608986 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31183022 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30210236 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29739388 |
| 83 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29572690 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28191783 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28147222 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27109517 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27109517 |
| 88 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26742139 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26028971 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24187763 |
| 91 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24022228 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23196604 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22890148 |
| 94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22641424 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22641424 |
| 96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22500985 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20573563 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19757001 |
| 99 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18464373 |
| 100 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17408322 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17070159 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16242633 |
| 103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15875918 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15661189 |
| 105 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15629531 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15606794 |
| 107 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.15184414 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14630268 |
| 109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14155842 |
| 110 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13978895 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13063511 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12573883 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12393366 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11941140 |
| 115 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11846449 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10861340 |
| 117 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10606605 |
| 118 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10184297 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10004288 |
| 120 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09418224 |
| 121 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09194351 |
| 122 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09143995 |
| 123 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09143995 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09059446 |
| 125 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08514049 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07295875 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06279631 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05263795 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04333426 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03818341 |
| 131 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03373743 |
| 132 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03232585 |
| 133 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02732459 |
| 134 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01914436 |
| 135 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01895758 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00753831 |
| 137 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00382189 |
| 138 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00320362 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00227139 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98998419 |
| 141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97590642 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95731328 |
| 143 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95488375 |
| 144 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94576299 |
| 145 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94576299 |
| 146 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91079449 |
| 147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89376356 |
| 148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89070436 |
| 149 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88569826 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87534672 |
| 151 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87379731 |
| 152 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84407944 |
| 153 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.81784739 |
| 154 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81485973 |
| 155 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79423745 |
| 156 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79091177 |
| 157 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78881554 |
| 158 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77029135 |
| 159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76942730 |
| 160 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75834039 |
| 161 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75147815 |
| 162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74856939 |
| 163 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73998582 |
| 164 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73214956 |
| 165 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72725465 |
| 166 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.71296369 |
| 167 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70532305 |
| 168 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69387326 |
| 169 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68747331 |
| 170 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67976893 |
| 171 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67073444 |
| 172 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66906967 |
| 173 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65977476 |
| 174 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65380471 |
| 175 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.65003121 |
| 176 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64619364 |
| 177 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64361566 |
| 178 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62818740 |
| 179 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62064976 |
| 180 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61222790 |
| 181 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60944107 |
| 182 | ATF3_27146783_Chip-Seq_COLON_Human | 0.60809430 |
| 183 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60348598 |
| 184 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60002488 |
| 185 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59815443 |
| 186 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.59192792 |
| 187 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58088134 |
| 188 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57706301 |
| 189 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57390692 |
| 190 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57071262 |
| 191 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56922482 |
| 192 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56866520 |
| 193 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.56196444 |
| 194 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.55760839 |
| 195 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54190558 |
| 196 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53738167 |
| 197 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.53289512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.01011819 |
| 2 | MP0005360_urolithiasis | 6.42694511 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.36753851 |
| 4 | MP0005365_abnormal_bile_salt | 5.26519024 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.43441732 |
| 6 | MP0005646_abnormal_pituitary_gland | 4.12114524 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.65627204 |
| 8 | MP0003252_abnormal_bile_duct | 3.46807600 |
| 9 | MP0004885_abnormal_endolymph | 3.30543715 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.17145268 |
| 11 | MP0009840_abnormal_foam_cell | 2.99565341 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.88914022 |
| 13 | MP0005083_abnormal_biliary_tract | 2.86760056 |
| 14 | MP0003195_calcinosis | 2.73481078 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 2.67049342 |
| 16 | MP0005332_abnormal_amino_acid | 2.60606777 |
| 17 | MP0002102_abnormal_ear_morphology | 2.58058595 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.51852317 |
| 19 | MP0003283_abnormal_digestive_organ | 2.51272527 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.46742151 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.42878653 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.27738720 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.16893655 |
| 24 | MP0002736_abnormal_nociception_after | 2.13000598 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.10266378 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.08880064 |
| 27 | MP0000609_abnormal_liver_physiology | 2.01434368 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.99041708 |
| 29 | MP0006292_abnormal_olfactory_placode | 1.92288069 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.91214947 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.89942091 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.81459649 |
| 33 | MP0009745_abnormal_behavioral_response | 1.75486500 |
| 34 | MP0004130_abnormal_muscle_cell | 1.70585837 |
| 35 | MP0001486_abnormal_startle_reflex | 1.69035337 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.68405329 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.66760052 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65372342 |
| 39 | MP0002272_abnormal_nervous_system | 1.64547765 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.61250953 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.56720334 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.53908850 |
| 43 | MP0000631_abnormal_neuroendocrine_gland | 1.52795252 |
| 44 | MP0003868_abnormal_feces_composition | 1.50626421 |
| 45 | MP0002160_abnormal_reproductive_system | 1.46498424 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.46466475 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.41939085 |
| 48 | MP0004142_abnormal_muscle_tone | 1.41924970 |
| 49 | MP0003879_abnormal_hair_cell | 1.41202639 |
| 50 | MP0000427_abnormal_hair_cycle | 1.41197015 |
| 51 | MP0005670_abnormal_white_adipose | 1.36536996 |
| 52 | MP0008872_abnormal_physiological_respon | 1.34977129 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.34967836 |
| 54 | MP0000372_irregular_coat_pigmentation | 1.33544973 |
| 55 | MP0009046_muscle_twitch | 1.31922904 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.30022626 |
| 57 | MP0005389_reproductive_system_phenotype | 1.29775145 |
| 58 | MP0005253_abnormal_eye_physiology | 1.29203480 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.28853868 |
| 60 | MP0005451_abnormal_body_composition | 1.27633756 |
| 61 | MP0002064_seizures | 1.26031076 |
| 62 | MP0003119_abnormal_digestive_system | 1.25485222 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.25454650 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.24355755 |
| 65 | MP0003186_abnormal_redox_activity | 1.24322844 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.22410973 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.22006907 |
| 68 | MP0003880_abnormal_central_pattern | 1.21181927 |
| 69 | MP0004924_abnormal_behavior | 1.20298705 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.20298705 |
| 71 | MP0000383_abnormal_hair_follicle | 1.19766607 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.16895894 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.15793071 |
| 74 | MP0010368_abnormal_lymphatic_system | 1.13839088 |
| 75 | MP0003787_abnormal_imprinting | 1.12413343 |
| 76 | MP0000598_abnormal_liver_morphology | 1.11161562 |
| 77 | MP0001764_abnormal_homeostasis | 1.10716299 |
| 78 | MP0003635_abnormal_synaptic_transmissio | 1.10715881 |
| 79 | MP0002971_abnormal_brown_adipose | 1.08606881 |
| 80 | MP0000013_abnormal_adipose_tissue | 1.03733933 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.03631950 |
| 82 | MP0000604_amyloidosis | 1.02038365 |
| 83 | MP0001664_abnormal_digestion | 1.01701168 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.01298628 |
| 85 | MP0005330_cardiomyopathy | 1.01078998 |
| 86 | MP0004085_abnormal_heartbeat | 0.99458997 |
| 87 | MP0009764_decreased_sensitivity_to | 0.99083573 |
| 88 | MP0003011_delayed_dark_adaptation | 0.97421814 |
| 89 | MP0002733_abnormal_thermal_nociception | 0.97112760 |
| 90 | MP0009763_increased_sensitivity_to | 0.95048519 |
| 91 | MP0002572_abnormal_emotion/affect_behav | 0.94713933 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.94676421 |
| 93 | MP0002063_abnormal_learning/memory/cond | 0.93574124 |
| 94 | MP0001970_abnormal_pain_threshold | 0.93455459 |
| 95 | MP0003938_abnormal_ear_development | 0.91720342 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.91216034 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.90914468 |
| 98 | MP0004084_abnormal_cardiac_muscle | 0.90226160 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.90082473 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.89652204 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.89601218 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.89279245 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.89231007 |
| 104 | MP0005334_abnormal_fat_pad | 0.88590160 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.88072454 |
| 106 | MP0008469_abnormal_protein_level | 0.87528365 |
| 107 | MP0009697_abnormal_copulation | 0.86756045 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.85586164 |
| 109 | MP0005647_abnormal_sex_gland | 0.85357410 |
| 110 | MP0005187_abnormal_penis_morphology | 0.85226311 |
| 111 | MP0004484_altered_response_of | 0.84055492 |
| 112 | MP0000613_abnormal_salivary_gland | 0.83254962 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.83060785 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.82892230 |
| 115 | MP0001919_abnormal_reproductive_system | 0.82888912 |
| 116 | MP0004270_analgesia | 0.82250365 |
| 117 | MP0005535_abnormal_body_temperature | 0.82126837 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.81953178 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.81061854 |
| 120 | MP0008995_early_reproductive_senescence | 0.80672183 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.80659768 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.79434343 |
| 123 | MP0001984_abnormal_olfaction | 0.78275432 |
| 124 | MP0005410_abnormal_fertilization | 0.77843841 |
| 125 | MP0004147_increased_porphyrin_level | 0.76915229 |
| 126 | MP0001661_extended_life_span | 0.76806458 |
| 127 | MP0001756_abnormal_urination | 0.76385412 |
| 128 | MP0003329_amyloid_beta_deposits | 0.76232232 |
| 129 | MP0003690_abnormal_glial_cell | 0.76031418 |
| 130 | MP0003300_gastrointestinal_ulcer | 0.75401463 |
| 131 | MP0002229_neurodegeneration | 0.75366783 |
| 132 | MP0004134_abnormal_chest_morphology | 0.75064947 |
| 133 | MP0010678_abnormal_skin_adnexa | 0.74979204 |
| 134 | MP0003646_muscle_fatigue | 0.73525382 |
| 135 | MP0005058_abnormal_lysosome_morphology | 0.73342594 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.72670704 |
| 137 | MP0003724_increased_susceptibility_to | 0.72387144 |
| 138 | MP0005275_abnormal_skin_tensile | 0.72242319 |
| 139 | MP0000049_abnormal_middle_ear | 0.72038960 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.70945564 |
| 141 | MP0001944_abnormal_pancreas_morphology | 0.70046678 |
| 142 | MP0003279_aneurysm | 0.68507227 |
| 143 | MP0004087_abnormal_muscle_fiber | 0.68467419 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.68181122 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.65865976 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.65865976 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.64748966 |
| 148 | MP0000749_muscle_degeneration | 0.63584246 |
| 149 | MP0000751_myopathy | 0.62982566 |
| 150 | MP0005408_hypopigmentation | 0.62522005 |
| 151 | MP0002269_muscular_atrophy | 0.62277557 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.62030741 |
| 153 | MP0008775_abnormal_heart_ventricle | 0.61980637 |
| 154 | MP0010630_abnormal_cardiac_muscle | 0.61318223 |
| 155 | MP0005448_abnormal_energy_balance | 0.61067017 |
| 156 | MP0005266_abnormal_metabolism | 0.59731748 |
| 157 | MP0002254_reproductive_system_inflammat | 0.58969444 |
| 158 | MP0009115_abnormal_fat_cell | 0.58156163 |
| 159 | MP0009053_abnormal_anal_canal | 0.57212700 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.57201644 |
| 161 | MP0006035_abnormal_mitochondrial_morpho | 0.57139626 |
| 162 | MP0003075_altered_response_to | 0.57097717 |
| 163 | MP0005464_abnormal_platelet_physiology | 0.56972675 |
| 164 | MP0002972_abnormal_cardiac_muscle | 0.56255095 |
| 165 | MP0004043_abnormal_pH_regulation | 0.55584832 |
| 166 | MP0006138_congestive_heart_failure | 0.55252029 |
| 167 | MP0000249_abnormal_blood_vessel | 0.54649390 |
| 168 | MP0005165_increased_susceptibility_to | 0.53954275 |
| 169 | MP0009765_abnormal_xenobiotic_induced | 0.53121043 |
| 170 | MP0000747_muscle_weakness | 0.52865344 |
| 171 | MP0003566_abnormal_cell_adhesion | 0.52153493 |
| 172 | MP0003436_decreased_susceptibility_to | 0.51677720 |
| 173 | MP0002970_abnormal_white_adipose | 0.49819712 |
| 174 | MP0008961_abnormal_basal_metabolism | 0.49398275 |
| 175 | MP0002168_other_aberrant_phenotype | 0.49068547 |
| 176 | MP0005166_decreased_susceptibility_to | 0.48527344 |
| 177 | MP0005167_abnormal_blood-brain_barrier | 0.48453382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.16235161 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.98414222 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.81031751 |
| 4 | Xanthomatosis (HP:0000991) | 5.44122672 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.11943735 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.82024488 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.78610914 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.65683351 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.64230774 |
| 10 | Hyperammonemia (HP:0001987) | 4.43196071 |
| 11 | Ketosis (HP:0001946) | 4.39255671 |
| 12 | Complement deficiency (HP:0004431) | 4.24328708 |
| 13 | Hyperglycinuria (HP:0003108) | 3.94277109 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.93444393 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.85006773 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82732798 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.82732798 |
| 18 | Hyperglycinemia (HP:0002154) | 3.76629543 |
| 19 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.72883989 |
| 20 | Short 1st metacarpal (HP:0010034) | 3.72883989 |
| 21 | Abnormality of the renal cortex (HP:0011035) | 3.71848049 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.71336338 |
| 23 | Ketoacidosis (HP:0001993) | 3.69445117 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.67416512 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.65675742 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61691397 |
| 27 | Joint hemorrhage (HP:0005261) | 3.60341338 |
| 28 | Epidermoid cyst (HP:0200040) | 3.58783282 |
| 29 | Pancreatic cysts (HP:0001737) | 3.56594010 |
| 30 | Congenital stationary night blindness (HP:0007642) | 3.54206956 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.50482427 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.37485810 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.32351610 |
| 34 | Abnormality of the 1st metacarpal (HP:0010009) | 3.32336902 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22696687 |
| 36 | Morphological abnormality of the middle ear (HP:0008609) | 3.20038899 |
| 37 | Fat malabsorption (HP:0002630) | 3.19659039 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 3.13265847 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.12224014 |
| 40 | Abnormality of complement system (HP:0005339) | 3.11543115 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.09336869 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.09336869 |
| 43 | Pancreatic fibrosis (HP:0100732) | 3.01192810 |
| 44 | Hyperventilation (HP:0002883) | 3.00969923 |
| 45 | True hermaphroditism (HP:0010459) | 2.98366183 |
| 46 | Nephronophthisis (HP:0000090) | 2.97943193 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.97917346 |
| 48 | Congenital sensorineural hearing impairment (HP:0008527) | 2.97027630 |
| 49 | Abnormality of the nasal septum (HP:0000419) | 2.90984888 |
| 50 | Large for gestational age (HP:0001520) | 2.90497111 |
| 51 | Absent phalangeal crease (HP:0006109) | 2.90456473 |
| 52 | Methylmalonic acidemia (HP:0002912) | 2.84155304 |
| 53 | Hyperbilirubinemia (HP:0002904) | 2.77744415 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.77054134 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.77054134 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 2.76457898 |
| 57 | Skin nodule (HP:0200036) | 2.75498215 |
| 58 | Myocardial infarction (HP:0001658) | 2.72807534 |
| 59 | Keratoconus (HP:0000563) | 2.71995209 |
| 60 | Increased corneal curvature (HP:0100692) | 2.71995209 |
| 61 | Myoglobinuria (HP:0002913) | 2.70418797 |
| 62 | Metabolic acidosis (HP:0001942) | 2.70305248 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.68392521 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.65271028 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.65032713 |
| 66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.64503130 |
| 67 | Hypoplasia of the fovea (HP:0007750) | 2.64503130 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.64273422 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.64006367 |
| 70 | Abolished electroretinogram (ERG) (HP:0000550) | 2.63055914 |
| 71 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.62382622 |
| 72 | Abnormality of serum amino acid levels (HP:0003112) | 2.59437996 |
| 73 | Progressive cerebellar ataxia (HP:0002073) | 2.57243280 |
| 74 | Short hallux (HP:0010109) | 2.55675295 |
| 75 | Febrile seizures (HP:0002373) | 2.55433014 |
| 76 | Abnormal finger flexion creases (HP:0006143) | 2.54292266 |
| 77 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.52604692 |
| 78 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.52367114 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.51538501 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.50431118 |
| 81 | Broad-based gait (HP:0002136) | 2.50002585 |
| 82 | Pendular nystagmus (HP:0012043) | 2.46424835 |
| 83 | Gout (HP:0001997) | 2.45964186 |
| 84 | Lethargy (HP:0001254) | 2.43660839 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41702387 |
| 86 | Short phalanx of the thumb (HP:0009660) | 2.41248753 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 2.40501985 |
| 88 | Genetic anticipation (HP:0003743) | 2.40459431 |
| 89 | Steatorrhea (HP:0002570) | 2.39241800 |
| 90 | Cholelithiasis (HP:0001081) | 2.38746638 |
| 91 | Cerebral edema (HP:0002181) | 2.38726430 |
| 92 | Asplenia (HP:0001746) | 2.37979698 |
| 93 | Hemiparesis (HP:0001269) | 2.36783381 |
| 94 | Chorioretinal atrophy (HP:0000533) | 2.34463251 |
| 95 | Tubular atrophy (HP:0000092) | 2.33878284 |
| 96 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.32422147 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30750296 |
| 98 | Methylmalonic aciduria (HP:0012120) | 2.30566189 |
| 99 | Decreased circulating renin level (HP:0003351) | 2.30531947 |
| 100 | Mitral stenosis (HP:0001718) | 2.30457828 |
| 101 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.29860622 |
| 102 | Esophageal varix (HP:0002040) | 2.27019154 |
| 103 | Polydipsia (HP:0001959) | 2.25768815 |
| 104 | Abnormal drinking behavior (HP:0030082) | 2.25768815 |
| 105 | Focal motor seizures (HP:0011153) | 2.25348218 |
| 106 | Late onset (HP:0003584) | 2.24078744 |
| 107 | Systemic lupus erythematosus (HP:0002725) | 2.23927839 |
| 108 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.23280620 |
| 109 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.22350986 |
| 110 | Vascular calcification (HP:0004934) | 2.21894026 |
| 111 | Spastic diplegia (HP:0001264) | 2.21585409 |
| 112 | Abnormality of alanine metabolism (HP:0010916) | 2.21569468 |
| 113 | Hyperalaninemia (HP:0003348) | 2.21569468 |
| 114 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.21569468 |
| 115 | Cholecystitis (HP:0001082) | 2.21483050 |
| 116 | Abnormal gallbladder physiology (HP:0012438) | 2.21483050 |
| 117 | Congenital, generalized hypertrichosis (HP:0004540) | 2.20656407 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 2.19053952 |
| 119 | Bilateral microphthalmos (HP:0007633) | 2.18305609 |
| 120 | Vomiting (HP:0002013) | 2.15646385 |
| 121 | Medial flaring of the eyebrow (HP:0010747) | 2.14575817 |
| 122 | Clumsiness (HP:0002312) | 2.14251916 |
| 123 | Agitation (HP:0000713) | 2.13915104 |
| 124 | Amyloidosis (HP:0011034) | 2.13844121 |
| 125 | Rhabdomyolysis (HP:0003201) | 2.13816346 |
| 126 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13286285 |
| 127 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.12815249 |
| 128 | Sensorimotor neuropathy (HP:0007141) | 2.12702239 |
| 129 | Thyroiditis (HP:0100646) | 2.12540570 |
| 130 | Cardiovascular calcification (HP:0011915) | 2.12226183 |
| 131 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11448539 |
| 132 | Cystic liver disease (HP:0006706) | 2.11342377 |
| 133 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.11018380 |
| 134 | Short tibia (HP:0005736) | 2.09637190 |
| 135 | Neonatal onset (HP:0003623) | 2.08429390 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 2.07795950 |
| 137 | Hydroxyprolinuria (HP:0003080) | 2.07795950 |
| 138 | Nausea (HP:0002018) | 2.07402775 |
| 139 | Abnormality of the fovea (HP:0000493) | 2.07284217 |
| 140 | Proximal tubulopathy (HP:0000114) | 2.04612976 |
| 141 | Right ventricular cardiomyopathy (HP:0011663) | 2.04264233 |
| 142 | Pancreatitis (HP:0001733) | 2.03421219 |
| 143 | Focal seizures (HP:0007359) | 2.02892044 |
| 144 | Decreased central vision (HP:0007663) | 2.02808668 |
| 145 | Abnormality of vitamin B metabolism (HP:0004340) | 2.00395217 |
| 146 | Progressive inability to walk (HP:0002505) | 2.00133178 |
| 147 | Metabolic alkalosis (HP:0200114) | 1.99779158 |
| 148 | Stomach cancer (HP:0012126) | 1.98063557 |
| 149 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.97198655 |
| 150 | Spontaneous abortion (HP:0005268) | 1.96516116 |
| 151 | Syncope (HP:0001279) | 1.95172642 |
| 152 | Hyperglycemia (HP:0003074) | 1.94998858 |
| 153 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94812990 |
| 154 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.92737488 |
| 155 | Abnormality of the gallbladder (HP:0005264) | 1.92214182 |
| 156 | Type II lissencephaly (HP:0007260) | 1.92086020 |
| 157 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.91679678 |
| 158 | Prostate neoplasm (HP:0100787) | 1.89668487 |
| 159 | Hemorrhage of the eye (HP:0011885) | 1.89655759 |
| 160 | Polycythemia (HP:0001901) | 1.88823452 |
| 161 | Axonal loss (HP:0003447) | 1.87789928 |
| 162 | Calf muscle hypertrophy (HP:0008981) | 1.87489706 |
| 163 | Abnormality of the renal collecting system (HP:0004742) | 1.86942570 |
| 164 | Glomerulonephritis (HP:0000099) | 1.86767107 |
| 165 | Irritability (HP:0000737) | 1.86594143 |
| 166 | Absent speech (HP:0001344) | 1.86166901 |
| 167 | Renal cortical cysts (HP:0000803) | 1.85860199 |
| 168 | Malnutrition (HP:0004395) | 1.85509417 |
| 169 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.83843310 |
| 170 | Tented upper lip vermilion (HP:0010804) | 1.83607115 |
| 171 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81017392 |
| 172 | Menorrhagia (HP:0000132) | 1.80748132 |
| 173 | Glycosuria (HP:0003076) | 1.77852229 |
| 174 | Abnormality of urine glucose concentration (HP:0011016) | 1.77852229 |
| 175 | Abnormality of iron homeostasis (HP:0011031) | 1.77343635 |
| 176 | Inability to walk (HP:0002540) | 1.77332858 |
| 177 | Hyperuricemia (HP:0002149) | 1.77315761 |
| 178 | Increased purine levels (HP:0004368) | 1.77315761 |
| 179 | Congenital hepatic fibrosis (HP:0002612) | 1.76431991 |
| 180 | Tachypnea (HP:0002789) | 1.75712236 |
| 181 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.75638252 |
| 182 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.75264039 |
| 183 | Increased muscle lipid content (HP:0009058) | 1.75004688 |
| 184 | Chronic hepatic failure (HP:0100626) | 1.74925871 |
| 185 | Furrowed tongue (HP:0000221) | 1.74723834 |
| 186 | Acanthocytosis (HP:0001927) | 1.74632122 |
| 187 | Hepatic necrosis (HP:0002605) | 1.74428671 |
| 188 | Exercise-induced myalgia (HP:0003738) | 1.74128288 |
| 189 | Hypertriglyceridemia (HP:0002155) | 1.73699186 |
| 190 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73197312 |
| 191 | Goiter (HP:0000853) | 1.72153232 |
| 192 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71291863 |
| 193 | Absent/shortened dynein arms (HP:0200106) | 1.71291863 |
| 194 | Male pseudohermaphroditism (HP:0000037) | 1.70531268 |
| 195 | Hemiplegia (HP:0002301) | 1.70456776 |
| 196 | Polyuria (HP:0000103) | 1.70363896 |
| 197 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.69708334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.27410363 |
| 2 | ERN1 | 4.16362034 |
| 3 | TRIB3 | 4.03600688 |
| 4 | PKN2 | 3.42437240 |
| 5 | SIK1 | 3.38094566 |
| 6 | FGFR4 | 2.91447594 |
| 7 | GRK1 | 2.76228357 |
| 8 | INSRR | 2.61329519 |
| 9 | TAOK3 | 2.58084801 |
| 10 | ACVR1B | 2.52662230 |
| 11 | ADRBK2 | 2.35530786 |
| 12 | MAPK13 | 2.31654103 |
| 13 | TTN | 2.25472430 |
| 14 | BMPR1B | 2.12930247 |
| 15 | TXK | 2.08996471 |
| 16 | NUAK1 | 2.04026686 |
| 17 | FLT3 | 2.01111820 |
| 18 | MAP4K2 | 2.00495749 |
| 19 | PTK6 | 1.96144775 |
| 20 | EPHB1 | 1.80868453 |
| 21 | WNK3 | 1.78009740 |
| 22 | MST1R | 1.64536201 |
| 23 | TLK1 | 1.61347987 |
| 24 | STK39 | 1.52609020 |
| 25 | OXSR1 | 1.52301618 |
| 26 | CASK | 1.49251222 |
| 27 | MARK1 | 1.46486257 |
| 28 | NEK9 | 1.46074713 |
| 29 | RIPK1 | 1.41732979 |
| 30 | NTRK3 | 1.41180928 |
| 31 | KDR | 1.40433920 |
| 32 | TEC | 1.38045232 |
| 33 | PDK4 | 1.35539724 |
| 34 | PDK3 | 1.35539724 |
| 35 | TYK2 | 1.34778045 |
| 36 | PLK2 | 1.33466047 |
| 37 | PIK3CG | 1.29536938 |
| 38 | ZAK | 1.26878493 |
| 39 | MAP3K7 | 1.26159094 |
| 40 | MYLK | 1.23637096 |
| 41 | EIF2AK3 | 1.23472066 |
| 42 | MAP3K10 | 1.21281462 |
| 43 | MAP2K3 | 1.21030361 |
| 44 | TIE1 | 1.18075260 |
| 45 | MET | 1.16676504 |
| 46 | PDGFRA | 1.16301108 |
| 47 | ERBB4 | 1.15218602 |
| 48 | TGFBR2 | 1.14864661 |
| 49 | LATS1 | 1.13989910 |
| 50 | CAMK1D | 1.13202928 |
| 51 | TNIK | 1.11798776 |
| 52 | JAK1 | 1.09522425 |
| 53 | MAP2K4 | 1.09131316 |
| 54 | MAPKAPK3 | 1.06975952 |
| 55 | TBK1 | 1.06917593 |
| 56 | LRRK2 | 1.06222187 |
| 57 | MAPK11 | 1.05236505 |
| 58 | MAP2K6 | 1.05037389 |
| 59 | LMTK2 | 1.03403081 |
| 60 | GRK7 | 1.00508900 |
| 61 | PRKAA2 | 0.99784583 |
| 62 | JAK2 | 0.98000822 |
| 63 | ADRBK1 | 0.96125334 |
| 64 | GRK5 | 0.92885488 |
| 65 | MAP3K4 | 0.89869235 |
| 66 | SGK2 | 0.89610155 |
| 67 | ITK | 0.88986606 |
| 68 | MAP3K3 | 0.87505415 |
| 69 | ERBB3 | 0.86797645 |
| 70 | ABL2 | 0.86766125 |
| 71 | WNK4 | 0.86464356 |
| 72 | RET | 0.85940455 |
| 73 | AKT3 | 0.80899996 |
| 74 | PHKG2 | 0.80200926 |
| 75 | PHKG1 | 0.80200926 |
| 76 | FGFR2 | 0.78581620 |
| 77 | PTK2 | 0.78232527 |
| 78 | EEF2K | 0.78145570 |
| 79 | NLK | 0.77061027 |
| 80 | FRK | 0.76660215 |
| 81 | MAPK12 | 0.76002771 |
| 82 | CAMK1G | 0.75113091 |
| 83 | PIK3CA | 0.75111969 |
| 84 | PAK3 | 0.74609785 |
| 85 | CSK | 0.74364874 |
| 86 | PRKD1 | 0.74241084 |
| 87 | PDK2 | 0.73419567 |
| 88 | PDPK1 | 0.72751238 |
| 89 | MAP3K9 | 0.71840307 |
| 90 | MAP2K1 | 0.71630365 |
| 91 | PRKCE | 0.71624765 |
| 92 | CSNK1G2 | 0.70476003 |
| 93 | MAPKAPK5 | 0.69748542 |
| 94 | ABL1 | 0.68067920 |
| 95 | TNK2 | 0.68054204 |
| 96 | EPHA3 | 0.66888633 |
| 97 | CDK6 | 0.65780476 |
| 98 | SYK | 0.64433959 |
| 99 | MAP2K2 | 0.64076474 |
| 100 | PRKCG | 0.64032910 |
| 101 | CAMKK2 | 0.63950216 |
| 102 | TRPM7 | 0.63441736 |
| 103 | PINK1 | 0.63042228 |
| 104 | PLK4 | 0.62702291 |
| 105 | CSNK1G1 | 0.62698000 |
| 106 | PAK2 | 0.61633284 |
| 107 | BMX | 0.60928037 |
| 108 | NTRK2 | 0.60827559 |
| 109 | MAP3K5 | 0.57863814 |
| 110 | CAMK2A | 0.57861161 |
| 111 | FGFR3 | 0.57822037 |
| 112 | KSR2 | 0.57428451 |
| 113 | OBSCN | 0.57047656 |
| 114 | GSK3A | 0.54955763 |
| 115 | DYRK1B | 0.54660722 |
| 116 | MAP3K11 | 0.54445757 |
| 117 | MUSK | 0.53509269 |
| 118 | CSNK1G3 | 0.53432855 |
| 119 | PRKACA | 0.53210834 |
| 120 | ERBB2 | 0.53035376 |
| 121 | PAK6 | 0.51893328 |
| 122 | PRKACG | 0.51810919 |
| 123 | STK11 | 0.51318271 |
| 124 | STK3 | 0.51278971 |
| 125 | MAPK4 | 0.51005023 |
| 126 | MAP3K1 | 0.50082068 |
| 127 | TRIM28 | 0.50035451 |
| 128 | PKN1 | 0.49817401 |
| 129 | PDK1 | 0.49090736 |
| 130 | EPHB2 | 0.48958452 |
| 131 | MAP3K2 | 0.48277190 |
| 132 | SGK1 | 0.47985405 |
| 133 | MAP4K1 | 0.47913698 |
| 134 | CSNK1A1L | 0.47463072 |
| 135 | IRAK3 | 0.47376724 |
| 136 | DMPK | 0.47302595 |
| 137 | PRKCH | 0.46652429 |
| 138 | DAPK2 | 0.46451603 |
| 139 | PRKAA1 | 0.46410465 |
| 140 | FER | 0.46102291 |
| 141 | STK24 | 0.45415344 |
| 142 | KIT | 0.44974493 |
| 143 | MTOR | 0.42951875 |
| 144 | ZAP70 | 0.42794619 |
| 145 | EPHA4 | 0.42198403 |
| 146 | STK38L | 0.42022355 |
| 147 | GRK6 | 0.42015004 |
| 148 | PDGFRB | 0.41715605 |
| 149 | PRKG1 | 0.41696979 |
| 150 | CAMK4 | 0.41471058 |
| 151 | ICK | 0.41153861 |
| 152 | CCNB1 | 0.40777602 |
| 153 | CSNK1A1 | 0.40385685 |
| 154 | IKBKB | 0.40163016 |
| 155 | SGK494 | 0.39106520 |
| 156 | SGK223 | 0.39106520 |
| 157 | PRKG2 | 0.38659225 |
| 158 | PRKCQ | 0.38404377 |
| 159 | IGF1R | 0.38335340 |
| 160 | PRKCA | 0.37444146 |
| 161 | MAPK3 | 0.37287943 |
| 162 | IKBKE | 0.37023105 |
| 163 | CAMK2D | 0.36862127 |
| 164 | PTK2B | 0.35385090 |
| 165 | JAK3 | 0.35277711 |
| 166 | RAF1 | 0.35271376 |
| 167 | CAMK1 | 0.35173408 |
| 168 | NME1 | 0.34717422 |
| 169 | FGFR1 | 0.34694809 |
| 170 | RPS6KA3 | 0.34672368 |
| 171 | CAMK2G | 0.34192128 |
| 172 | CAMKK1 | 0.33032952 |
| 173 | EIF2AK2 | 0.31833324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.87160207 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.24590377 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17362077 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08575950 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.01066963 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82041366 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69636287 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69387717 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.68598541 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61333205 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.57667131 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.55072585 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53343978 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30161127 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.29894299 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26554458 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21882159 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15564627 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13234428 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12503691 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10821184 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10697287 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06874274 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 2.01358760 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96773500 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92474760 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.82482338 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.76692469 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74272518 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73411406 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73391349 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70755691 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70407822 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70223868 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64519716 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64307503 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.59347293 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.59280909 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.57129807 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56749035 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.55684098 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54259142 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50105467 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48694217 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 1.46576436 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.45535034 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42217702 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41910431 |
| 49 | Taste transduction_Homo sapiens_hsa04742 | 1.41308033 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39171349 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38129141 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36984531 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36525073 |
| 54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29900098 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27680695 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25904296 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24167454 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23986417 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23209544 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22921300 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20318710 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19552651 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18935252 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 1.18692687 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18240977 |
| 66 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17966044 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 1.15938296 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 1.11927854 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08460059 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.06228878 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.04444448 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04403225 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99932115 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99069504 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96949893 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93724209 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93370990 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.91763517 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.91068187 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89789674 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86851342 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.86135270 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84055357 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81539341 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81308912 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80984828 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80104239 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79945551 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.78117735 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77714691 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77263905 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77230637 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76619309 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74907079 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74784836 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74401002 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74291096 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72214816 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70562461 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70455857 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68948520 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.68038610 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67588473 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66586793 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66401363 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62002572 |
| 107 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60059096 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60005822 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59837238 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59531026 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59011316 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.56476604 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55997543 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.53924268 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.50421934 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49133744 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44747113 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41431513 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41124559 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40187912 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39809791 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39501372 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35984705 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34519814 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32921476 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.32529214 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28924757 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.28772766 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25058911 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25006074 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22617248 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19059576 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18925247 |
| 134 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18784476 |
| 135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16838888 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15240570 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14675018 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10214105 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08908050 |
| 140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03556265 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.01571712 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1061740 |
| 143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1041464 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0991165 |
| 145 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0977839 |
| 146 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0950069 |
| 147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0773807 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0737337 |
| 149 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0716144 |
| 150 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0680568 |
| 151 | Lysosome_Homo sapiens_hsa04142 | -0.0673184 |
| 152 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0634640 |
| 153 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0633390 |
| 154 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0614544 |
| 155 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0607217 |
| 156 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0220663 |
| 157 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0190474 |

